| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
VP, Research
1 company
Fairman Jeff is a VP, Research at Vaxcyte, Inc.. Recent SEC Form 4 filings include 0 buys and 17 sells.
Estimated insider holdings value: $14.9M based on current market prices.
| Date | Ticker | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|
| Dec 9, 2021 | PCVX Vaxcyte, Inc. | VP, Research | Sale+OE | 131 | $22.50 | $2,947.50 | -2.1% | +14.7% | +98.2% | |
| Oct 26, 2021 | PCVX Vaxcyte, Inc. | VP, Research | Sale+OE | 4,750 | $22.69 | $107,777.50 | -48.0% | -19.7% | +80.1% | |
| Sep 27, 2021 | PCVX Vaxcyte, Inc. | VP, Research | Sale+OE | 4,750 | $26.17 | $124,303.09 | -31.3% | -11.8% | -6.7% | |
| Aug 26, 2021 | PCVX Vaxcyte, Inc. | VP, Research | Sale+OE | 4,750 | $25.38 | $120,543.00 | -26.0% | -15.4% | +11.2% | |
| Jul 26, 2021 | PCVX Vaxcyte, Inc. | VP, Research | Sale+OE | 4,750 | $22.70 | $107,825.00 | -48.0% | +0.2% | +5.0% | |
| Jun 28, 2021 | PCVX Vaxcyte, Inc. | VP, Research | Sale+OE | 4,750 | $24.37 | $115,769.84 | -31.3% | +9.1% | -13.2% | |
| Jun 7, 2021 | PCVX Vaxcyte, Inc. | VP, Research | Sale+OE | 9,500 | $22.50 | $213,750.00 | -64.9% | +12.7% | -13.9% | |
| Mar 26, 2021 | PCVX Vaxcyte, Inc. | VP, Research | Sale+OE | 4,750 | $23.88 | $113,433.24 | -53.2% | -1.5% | +0.8% | |
| Feb 26, 2021 | PCVX Vaxcyte, Inc. | VP, Research | Sale+OE | 4,750 | $23.93 | $113,663.22 | -45.3% | - | - | |
| Jan 26, 2021 | PCVX Vaxcyte, Inc. | VP, Research | Sale+OE | 4,750 | $25.27 | $120,014.50 | -59.4% | - | - |